167 related articles for article (PubMed ID: 34106490)
1. Association between serum ferritin, incident primary liver cancer, and chronic liver disease mortality in the Linxian Nutrition Intervention Trials: A nested case-control study.
Zhu Z; Yin J; Dawsey SM; Liu B; Freedman ND; Yin L; Taylor PR; Cui J; Fan J; Liu Y; Chen W; Qiao Y; Abnet CC
J Gastroenterol Hepatol; 2021 Dec; 36(12):3410-3417. PubMed ID: 34106490
[TBL] [Abstract][Full Text] [Related]
2. Association between serum 25(OH) vitamin D, incident liver cancer and chronic liver disease mortality in the Linxian Nutrition Intervention Trials: a nested case-control study.
Wang JB; Abnet CC; Chen W; Dawsey SM; Fan JH; Yin LY; Yin J; Major JM; Taylor PR; Qiao YL; Freedman ND
Br J Cancer; 2013 Oct; 109(7):1997-2004. PubMed ID: 24008664
[TBL] [Abstract][Full Text] [Related]
3. Serum ferritin and the risk of hepatocellular carcinoma in chronic liver disease of viral etiology: a case-control study.
Patil PS; Mohandas KM; Bhatia SJ; Mehta SA
Indian J Gastroenterol; 2014 Jan; 33(1):12-8. PubMed ID: 24006121
[TBL] [Abstract][Full Text] [Related]
4. Relationships between serum iron and liver diseases in nutrition intervention trials: A nested case-control study.
Liu Y; Yin J; Dawsey SM; Liu B; Freedman ND; Cui J; Taylor PR; Yin L; Abnet CC; Fan J; Chen W; Zhong L; Qiao Y
Cancer Epidemiol; 2022 Jun; 78():102157. PubMed ID: 35421712
[TBL] [Abstract][Full Text] [Related]
5. Association between C-reactive protein, incident liver cancer, and chronic liver disease mortality in the Linxian Nutrition Intervention Trials: a nested case-control study.
Chen W; Wang JB; Abnet CC; Dawsey SM; Fan JH; Yin LY; Yin J; Taylor PR; Qiao YL; Freedman ND
Cancer Epidemiol Biomarkers Prev; 2015 Feb; 24(2):386-92. PubMed ID: 25613115
[TBL] [Abstract][Full Text] [Related]
6. Associations between serum glucose, insulin, insulin resistance and the risk of incident primary liver cancer or chronic liver disease mortality: a nested case-control study.
Yin J; Freedman ND; Liu Y; Dawsey SM; Yang H; Taylor PR; Yin L; Liu B; Cui J; Fan J; Chen W; Qiao Y; Abnet CC
Br J Cancer; 2023 Jan; 128(2):275-284. PubMed ID: 36496451
[TBL] [Abstract][Full Text] [Related]
7. Association of 25-Hydroxyvitamin D with Liver Cancer Incidence and Chronic Liver Disease Mortality in Finnish Male Smokers of the ATBC Study.
Lai GY; Wang JB; Weinstein SJ; Parisi D; Horst RL; McGlynn KA; Männistö S; Albanes D; Freedman ND
Cancer Epidemiol Biomarkers Prev; 2018 Sep; 27(9):1075-1082. PubMed ID: 29720370
[No Abstract] [Full Text] [Related]
8. Chronic liver disease in central Harlem: the role of alcohol and viral hepatitis.
Frieden TR; Ozick L; McCord C; Nainan OV; Workman S; Comer G; Lee TP; Byun KS; Patel D; Henning KJ
Hepatology; 1999 Mar; 29(3):883-8. PubMed ID: 10051493
[TBL] [Abstract][Full Text] [Related]
9. Higher Glucose and Insulin Levels Are Associated with Risk of Liver Cancer and Chronic Liver Disease Mortality among Men without a History of Diabetes.
Loftfield E; Freedman ND; Lai GY; Weinstein SJ; McGlynn KA; Taylor PR; Männistö S; Albanes D; Stolzenberg-Solomon RZ
Cancer Prev Res (Phila); 2016 Nov; 9(11):866-874. PubMed ID: 27574287
[TBL] [Abstract][Full Text] [Related]
10. Association of serum α-tocopherol, β-carotene, and retinol with liver cancer incidence and chronic liver disease mortality.
Lai GY; Weinstein SJ; Albanes D; Taylor PR; Virtamo J; McGlynn KA; Freedman ND
Br J Cancer; 2014 Nov; 111(11):2163-71. PubMed ID: 25314058
[TBL] [Abstract][Full Text] [Related]
11. Serum ferritin levels predict incident non-alcoholic fatty liver disease in healthy Korean men.
Kim CW; Chang Y; Sung E; Shin H; Ryu S
Metabolism; 2012 Aug; 61(8):1182-8. PubMed ID: 22386931
[TBL] [Abstract][Full Text] [Related]
12. Combined effects of chronic hepatitis virus infections and substance-use habits on chronic liver diseases in Taiwanese aborigines.
Lin HH; Wang LY; Shaw CK; Cheng ML; Chung WK; Chiang HJ; Lin TY; Chen CJ
J Formos Med Assoc; 2002 Dec; 101(12):826-34. PubMed ID: 12632815
[TBL] [Abstract][Full Text] [Related]
13. Increased serum ferritin in chronic liver disease: a risk factor for primary hepatocellular carcinoma.
Hann HW; Kim CY; London WT; Blumberg BS
Int J Cancer; 1989 Mar; 43(3):376-9. PubMed ID: 2538399
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic value of serum ferritin in primary hepatocellular carcinoma.
Giannoulis E; Arvanitakis C; Nikopoulos A; Doutsos I; Tourkantonis A
Digestion; 1984; 30(4):236-41. PubMed ID: 6210220
[TBL] [Abstract][Full Text] [Related]
15. Disparity in liver cancer incidence and chronic liver disease mortality by nativity in Hispanics: The Multiethnic Cohort.
Setiawan VW; Wei PC; Hernandez BY; Lu SC; Monroe KR; Le Marchand L; Yuan JM
Cancer; 2016 May; 122(9):1444-52. PubMed ID: 26916271
[TBL] [Abstract][Full Text] [Related]
16. The diagnostic utility of serum ferritin. Estimation in patients with primary hepatocellular carcinoma.
Ola SO; Akanji AO; Ayoola EA
Trop Geogr Med; 1995; 47(6):302-4. PubMed ID: 8650746
[TBL] [Abstract][Full Text] [Related]
17. Plasma ferritin, C-reactive protein, and risk of incident type 2 diabetes in Singapore Chinese men and women.
Wang YL; Koh WP; Yuan JM; Pan A
Diabetes Res Clin Pract; 2017 Jun; 128():109-118. PubMed ID: 28448891
[TBL] [Abstract][Full Text] [Related]
18. Serum concentrations of 1,1,1-trichloro-2,2-bis(p-chlorophenyl)ethane (DDT) and 1,1-dichloro-2,2-bis(p-chlorophenyl)ethylene (DDE) and risk of primary liver cancer.
McGlynn KA; Abnet CC; Zhang M; Sun XD; Fan JH; O'Brien TR; Wei WQ; Ortiz-Conde BA; Dawsey SM; Weber JP; Taylor PR; Katki H; Mark SD; Qiao YL
J Natl Cancer Inst; 2006 Jul; 98(14):1005-10. PubMed ID: 16849683
[TBL] [Abstract][Full Text] [Related]
19. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
20. Hepcidin levels in children with chronic liver disease.
Cakir M; Erduran E; Turkmen ES; Aliyazicioglu Y; Reis GP; Cobanoglu U; Demir S
Saudi J Gastroenterol; 2015; 21(5):300-5. PubMed ID: 26458857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
